SCHEMBL2298852

SCHEMBL2298852

Fc1ccc(OCC2CC[N]CC2)cc1F

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 5/20 0.49
PARP15 Q460N3 4/20 0.49
FFAR4 Q5NUL3 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR3A P46098 1/20 0.41
KCNH2 Q12809 1/20 0.41
KDM1A O60341 1/20 0.40
FFAR1 O14842 2/20 0.40
PPARD Q03181 2/20 0.40
TRPV4 Q9HBA0 1/20 0.40
SCN9A Q15858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14901056 0.88 PARP10 (0.55) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL7034688 0.81 SIGMAR1 (0.45)
SCHEMBL9223677 0.81 PARP10 (0.49) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL9223680 0.81 PARP10 (0.49) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL9489146 0.79 PARP10 (0.48) PARP10PARP15FFAR4KDM1ASCN9A
SCHEMBL9227652 0.78 PARP10 (0.47) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL7760369 0.78 PARP10 (0.47) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL9227647 0.78 PARP10 (0.47) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL9226447 0.77 PARP10 (0.46) PARP10PARP15FFAR4SLC6A2SLC6A4
SCHEMBL15181001 0.77 PARP10 (0.46) PARP10PARP15FFAR4SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536689-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN Amgen Inc. (US) 2012-12-26 EP disclosed
WO-2011103196-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN AMGEN INC. (US) 2011-08-25 WO disclosed